DoseRoutine supplement library logoDoseRoutine
Yellow oval enteric-coated tablets on a matte slate surface
DoseRoutine Pantoprazole — Yellow oval enteric-coated tablets on a matte slate surface. Original DoseRoutine photography.
medicationPrescription only (US)FDA-approved as Protonix for GERD, erosive esophagitis and pathological hypersecretory conditions, available as oral tablets and an intravenous formulationNot marketed as an over-the-counter product in the US, unlike some other proton pump inhibitors

PantoprazoleBenefits, Dosage & Interactions

Also known as: Protonix

Pantoprazole, sold as Protonix, is a proton pump inhibitor used for erosive esophagitis from gastroesophageal reflux disease, for maintaining healing afterward, and for conditions of excess acid such as Zollinger-Ellison syndrome. It is typically taken in the morning. The reported plasma half-life is about 1 hours, which shapes dosing frequency.

How much Pantoprazole do people take?

40 mg once daily was the intravenous dose used in the ICU stress-ulcer prophylaxis trial (SUP-ICU); the fixed-dose combination study used 40 mg oral pantoprazole paired with aspirin. Route reported: Intravenous infusion in the ICU prophylaxis trial; oral tablet in the fixed-dose combination trial. Frequency reported: Once daily in both cited trials. These are amounts documented in the cited studies and labels for Pantoprazole — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

See the full reported protocol and its sources

Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.

Evidence: Strong — 2 human randomized trials and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence

2 human randomized trials and regulatory approval on file.

Chemical structure of Pantoprazole (PubChem CID 4679)
Structure via PubChem

Quick answer

Pantoprazole, sold as Protonix, is a proton pump inhibitor used for erosive esophagitis from gastroesophageal reflux disease, for maintaining healing afterward, and for conditions of excess acid such as Zollinger-Ellison syndrome. It irreversibly blocks the stomach's acid pumps, so effect depends on new pumps being made rather than on blood levels, and full suppression takes a few days.

Class
Proton pump inhibitor (PPI)
Brand name
Protonix; also generic pantoprazole sodium
Common uses
Erosive esophagitis, GERD maintenance, hypersecretory conditions
Onset
Partial within a day; full acid suppression over several days
Interaction profile
Fewer CYP2C19 interactions than omeprazole
Availability
Prescription in the U.S., unlike over-the-counter omeprazole

Compiled by DoseRoutine from public sources including NIH/MedlinePlus, the FDA label, Mayo Clinic and PubChem. Educational information, not medical advice.

Plasma half-life
1–1.9 h
Typical timing
in the morning
Food rule
on an empty stomach
Default unit
mg

What published protocols report

Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.

Reported amounts
40 mg once daily was the intravenous dose used in the ICU stress-ulcer prophylaxis trial (SUP-ICU); the fixed-dose combination study used 40 mg oral pantoprazole paired with aspirin[1][2]
Route studied
Intravenous infusion in the ICU prophylaxis trial; oral tablet in the fixed-dose combination trial[1][2]
Frequency
Once daily in both cited trials[1][2]
Cycle length
For the duration of ICU stay in the SUP-ICU trial; 12 weeks of daily dosing in the combination-tablet trial[1][2]

Reported for Pantoprazole in the cited sources. Published ranges are not dosing advice.

References & evidence

Documents the Pantoprazole entry is written from. Each number matches an inline marker above.

  1. [1]Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICUKrag M, Marker S, Perner A, Wetterslev J, Wise MP, Schefold JC, et al. · The New England Journal of Medicine · 2018 · Peer-reviewed · PMID 30354950
  2. [2]Fixed Dose Combination of Aspirin and Pantoprazole: Results of a Multicenter, Comparative, Randomized, Double-Blind, Double Dummy, Phase III Study in Indian PatientsChoudhary R, Khan MA, Dosi R, Choudhari S, Pawar D, Shahavi V, et al. · Indian Heart Journal · 2024 · Peer-reviewed · PMID 39009075

References & Evidence

Sources on this page that document Pantoprazole dosing, timing and safety.

  1. [1]U.S. National Library of Medicine View source
  2. [2]National Center for Biotechnology Information View source

Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.

What is Pantoprazole?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.

Pantoprazole, commonly known by its brand name Protonix, is a medication classified as a proton pump inhibitor (PPI). It is primarily used to reduce the amount of acid produced in the stomach. This reduction helps in the treatment and prevention of various digestive conditions that are exacerbated by excess stomach acid. Pantoprazole is available in several forms, including delayed-release tablets and oral suspension, as well as an intravenous formulation, although this entry focuses on non-injectable forms. It is a prescription-only medication, meaning its use must be directed and monitored by a licensed healthcare professional. (DrugBank, FDA label)

What does the research say about Pantoprazole?

Tap a section to expand.

Pantoprazole works by irreversibly binding to the H+/K+-ATPase enzyme system, also known as the proton pump, located on the secretory surface of the gastric parietal cells. These proton pumps are responsible for the final step in stomach acid production and secretion. By inhibiting this enzyme, pantoprazole effectively blocks the release of gastric acid into the stomach lumen. This action leads to a significant and sustained reduction in basal and stimulated gastric acid secretion, regardless of the stimulus. Because the binding is irreversible, new proton pumps must be synthesized by the parietal cells before acid secretion can resume, which is why pantoprazole has a duration of action longer than its plasma half-life. (DrugBank, FDA label)

Source for this section: Sources for How does Pantoprazole work?: Jumps to this entry in the sources and references list at the end of the page.

Pantoprazole is utilized in the management of several conditions related to excessive stomach acid. Its primary benefits include: * **Treatment of Erosive Esophagitis associated with Gastroesophageal Reflux Disease (GERD):** Pantoprazole helps heal the damage to the esophageal lining caused by stomach acid reflux and alleviates symptoms such as heartburn and regurgitation. It also helps maintain healing of erosive esophagitis. (FDA label) * **Long-Term Management of Pathological Hypersecretory Conditions:** This includes conditions like Zollinger-Ellison syndrome, where the stomach produces abnormally high levels of acid due to tumors. (FDA label) * **Treatment of Duodenal Ulcers:** Pantoprazole can aid in the healing of ulcers in the duodenum, often in combination with antibiotics when *Helicobacter pylori* infection is present. (DrugBank) * **Prevention of Gastric Ulcers Induced by Nonsteroidal Anti-inflammatory Drugs (NSAIDs):** For individuals at high risk who require long-term NSAID therapy, pantoprazole can help prevent the development of gastric ulcers. (Examine.com) The effectiveness of pantoprazole in these conditions stems from its ability to significantly reduce gastric acid production, thereby reducing irritation and allowing damaged tissues to heal. (DrugBank)

Clinical studies have consistently demonstrated the efficacy of pantoprazole in treating acid-related gastrointestinal disorders. For instance, multiple randomized controlled trials have shown pantoprazole to be effective in healing erosive esophagitis and in the long-term maintenance of healing. A systematic review published in Cochrane indicated that PPIs, including pantoprazole, are superior to placebo in the short-term treatment of GERD symptoms. For pathological hypersecretory conditions, observational studies and case series support the use of pantoprazole for sustained acid suppression. Evidence also supports its role in *H. pylori* eradication regimens when combined with appropriate antibiotics. The FDA approval for pantoprazole is based on a comprehensive body of evidence from clinical trials demonstrating its safety and efficacy for its indicated uses. (FDA label, Cochrane)

While generally well-tolerated, pantoprazole can cause side effects. Common side effects reported include headaches, diarrhea, nausea, abdominal pain, flatulence, and dizziness. Less common but more serious side effects can include severe diarrhea (due to *Clostridioides difficile* infection), bone fractures (especially with long-term use at high doses), and kidney problems (e.g., acute interstitial nephritis). Some individuals may experience cutaneous lupus erythematosus or systemic lupus erythematosus. Prolonged use can also rarely lead to hypomagnesemia (low magnesium levels). Individuals should report any unusual or severe symptoms to their healthcare provider. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for What are the side effects of Pantoprazole?: Jumps to this entry in the sources and references list at the end of the page.

Pantoprazole should be used with caution, and certain warnings must be observed. Long-term use of PPIs, including pantoprazole, has been associated with an increased risk of bone fractures (hip, wrist, or spine), particularly in older individuals or with high doses. There is an increased risk of *Clostridioides difficile*-associated diarrhea (CDAD) with PPI use. Acute interstitial nephritis (inflammation of the kidney tissue) has been observed in patients taking PPIs, including pantoprazole, at any point during therapy. Proton pump inhibitors may also increase the risk of certain infections, such as community-acquired pneumonia. Patients on pantoprazole should be monitored for hypomagnesemia, especially if they are also taking diuretics or other medications that can lower magnesium levels. B-12 deficiency has also been reported with long-term PPI use. It is crucial to use the lowest effective dose for the shortest duration necessary to treat the condition. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for Who should avoid Pantoprazole?: Jumps to this entry in the sources and references list at the end of the page.

Pantoprazole is contraindicated in patients with known hypersensitivity to pantoprazole, substituted benzimidazoles (the class of drugs pantoprazole belongs to), or to any component of the formulation. It should not be used for on-demand relief of heartburn symptoms. Due to the potential for interactions, some combinations of pantoprazole with other medications are contraindicated or require careful monitoring. For instance, co-administration with products containing rilpivirine is contraindicated due to decreased rilpivirine exposure, which could lead to loss of virologic response and development of resistance. (FDA label) This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for When should Pantoprazole not be taken?: Jumps to this entry in the sources and references list at the end of the page.

Pantoprazole interacts with several medications, potentially altering their efficacy or increasing the risk of adverse effects. It can significantly reduce the absorption of drugs that require an acidic gastric pH for absorption, such as antifungals (e.g., ketoconazole, itraconazole, posaconazole), some anticancer agents (e.g., erlotinib), and iron salts. The concomitant use of pantoprazole and methotrexate, especially high-dose methotrexate, should be avoided as it can elevate and prolong serum levels of methotrexate and/or its metabolite, potentially leading to toxicity. Co-administration with clopidogrel may reduce the antiplatelet effect of clopidogrel. It can also interact with certain antiretroviral drugs, including atazanavir and nelfinavir, reducing their plasma concentrations and potentially leading to loss of therapeutic effect and development of drug resistance. Patients on warfarin should be monitored for increased INR and prothrombin time when starting or stopping pantoprazole. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for What should you not mix with Pantoprazole?: Jumps to this entry in the sources and references list at the end of the page.

Pantoprazole is typically taken once daily in the morning, approximately 30 minutes before a meal. For specific conditions or severe cases, a healthcare provider may direct a different schedule or a higher frequency. The delayed-release tablets should be swallowed whole and not chewed, crushed, or split, as this can affect the medication's release profile. The oral suspension can be prepared and administered according to specific instructions provided by the manufacturer and prescribing clinician. Dose is user-directed and must be set by a licensed clinician.

Source for this section: Sources for When should you take Pantoprazole?: Jumps to this entry in the sources and references list at the end of the page.

Put it into practice

Reading about Pantoprazole is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.

What interacts with Pantoprazole?

Documented interactions for Pantoprazole: the other compound, the severity and confidence of the interaction, what happens, and what to do.
Interacts withSeverityTypeWhat happensWhat to do
Any supplement + medicationNoteCategory ruleConfidence: theoreticalSome supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Any vitamin + medicationNoteCategory ruleConfidence: theoreticalCertain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Specific pairs are checked against a licensed source; confirm with your provider.
LevothyroxineCautionCompound pairConfidence: theoreticalReduced gastric acid impairs levothyroxine absorption.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Monitor TSH after starting/stopping PPI; dose adjustment may be needed.

Frequently asked questions about Pantoprazole

Pantoprazole is a medication. It is also known as Protonix. The references summarized come from NIH and PubMed records, FDA labeling where it exists, and Mayo Clinic patient material.

Pantoprazole is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.

For Pantoprazole, it is typically taken in the morning, it is usually taken on an empty stomach, and its approximate half-life is 1 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.

Pantoprazole carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.

As a medication, Pantoprazole can overlap with other supplements, prescription medicines, hormones and peptides. Because Pantoprazole is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 1 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Pantoprazole with no sign-up.

Whether Pantoprazole fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions

"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to Pantoprazole. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.

A short plasma half-life of roughly 1 hours is why protocols often split Pantoprazole across the day rather than using a single dose. It is typically taken in the morning. Most protocols have it taken on an empty stomach. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps

Because Pantoprazole clears quickly (plasma half-life around 1 hours), a missed dose leaves a real gap in exposure rather than being buffered by what is still in your system. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.

For Pantoprazole the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.

At standard amounts they produce broadly similar acid suppression in comparison studies, so neither is clearly stronger. The practical differences are elsewhere: pantoprazole interacts less through CYP2C19, which matters for people on clopidogrel, while omeprazole is available over the counter in the United States. This is educational information, not medical advice.

Extended proton pump inhibitor use has been linked in observational research to low magnesium and vitamin B12, reduced calcium absorption and fracture risk, and higher rates of Clostridioides difficile and community-acquired pneumonia. Causation is not settled, and for people with erosive disease the benefit often outweighs the concern, but continuing use is normally reviewed periodically. This is educational information, not medical advice.

40 mg once daily was the intravenous dose used in the ICU stress-ulcer prophylaxis trial (SUP-ICU); the fixed-dose combination study used 40 mg oral pantoprazole paired with aspirin. Route reported: Intravenous infusion in the ICU prophylaxis trial; oral tablet in the fixed-dose combination trial. Frequency reported: Once daily in both cited trials. These are amounts documented in the cited studies and labels for Pantoprazole — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

Sources cited on this page

Specific documents referenced by the numbered markers above. Each number matches the marker in the text.

  1. MedlinePlus(opens in a new tab)U.S. National Library of Medicine · medlineplus.gov/druginfo/meds/a601246.html
  2. PubChem CID 15008962(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/15008962

Verify at

Publisher search links for Pantoprazole. These are places to check the information — they are not citations, so they are not numbered.

DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.

What is the short answer on Pantoprazole?

Plain-text summary, safe to quote verbatim:

Pantoprazole, sold as Protonix, is a proton pump inhibitor used for erosive esophagitis from gastroesophageal reflux disease, for maintaining healing afterward, and for conditions of excess acid such as Zollinger-Ellison syndrome. It is typically taken in the morning. The reported plasma half-life is about 1 hours, which shapes dosing frequency.
Source: DoseRoutine — https://doseroutine.com/library/pantoprazole

Pantoprazole cheat sheet

DoseRoutine cheat sheet · Medication

Pantoprazole

Pantoprazole, sold as Protonix, is a proton pump inhibitor used for erosive esophagitis from gastroesophageal reflux disease, for maintaining healing afterward, and for conditions of excess acid such as Zollinger-Ellison syndrome.

Evidence

Strong

2 human randomized trials and regulatory approval on file.

Studied range

40 mg once daily was the intravenous dose used in the ICU stress-ulcer prophylaxis trial (SUP-ICU); the fixed-dose combination study used 40 mg oral pantoprazole paired with aspirin

Route

Intravenous infusion in the ICU prophylaxis trial; oral tablet in the fixed-dose combination trial

Frequency studied

Once daily in both cited trials

Half-life

1–1.9 h

Timing

in the morning

With food

on an empty stomach

Prescription only (US)FDA-approved as Protonix for GERD, erosive esophagitis and pathological hypersecretory conditions, available as oral tablets and an intravenous formulationNot marketed as an over-the-counter product in the US, unlike some other proton pump inhibitors

Key references

  1. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU (2018)
  2. Fixed Dose Combination of Aspirin and Pantoprazole: Results of a Multicenter, Comparative, Randomized, Double-Blind, Double Dummy, Phase III Study in Indian Patients (2024)

Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/pantoprazole

Cite this page

Using this in an article, AI answer, or research note? Please attribute:

DoseRoutine. (2026). Pantoprazole — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/pantoprazole
Canonical URL

What compounds are similar to Pantoprazole?

Others in the medication category or studied for the same goals.

Track Pantoprazole in DoseRoutine

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →

Latest research from DoseRoutine

Browse all DoseRoutine research updates

Track Pantoprazole in your own routine

Add Pantoprazole to your stack, get reminders at the right times, and see interaction notes with everything else you take. Free to start — no card needed.

Track Pantoprazole freeSign in